Cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-022-06723-z.pdf
Reference32 articles.
1. Riboldi GM, Samanta D, Frucht S (2021) Ataxia Telangiectasia 2020. StatPearls [Internet]. StatPearls Publishing, Treasure Island
2. Swift M, Reitnauer PJ, Morrell D, Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316(21):1289–1294. https://doi.org/10.1056/NEJM198705213162101
3. Janin N, Andrieu N, Ossian K, Laugé A, Croquette M-F, Griscelli C et al (1999) Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families. Br J Cancer 80(7):1042–1045
4. Thompson D, Duedal S, Kirner J, McGuffog L, Last J, Reiman A et al (2005) Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst 97(11):813–822. https://doi.org/10.1093/jnci/dji141
5. Swift M, Morrell D, Massey RB, Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325(26):1831–1836. https://doi.org/10.1056/NEJM199112263252602
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Protein-truncating and rare missense variants inATMandCHEK2and associations with cancer in UK Biobank whole-exome sequence data;Journal of Medical Genetics;2024-08-29
2. A novel KCND3 variant in the N‐terminus impairs the ionic current of Kv4.3 and is associated with SCA19/22;Journal of Cellular and Molecular Medicine;2024-08
3. What's Changed in 75 Years of RadRes? – An Australian Perspective on Selected Topics;Radiation Research;2024-07-05
4. Protein-truncating and rare missense variants inATMandCHEK2and associations with cancer in UK Biobank whole-exome sequenced data;2024-07-03
5. Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years;Cancer;2024-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3